Anixa Biosciences, Inc.

ANIX · NASDAQ
Analyze with AI
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Assets
Cash & Equivalents$1,271$915$12,360$29,128
Short-Term Investments$18,653$22,929$17,327$6,600
Receivables$173$270$46$0
Inventory$0$0-$46$0
Other Curr. Assets$1,265$1,242$467$276
Total Curr. Assets$21,362$25,356$30,200$36,003
Property Plant & Equip (Net)$229$166$212$254
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0-$212$0
Total NC Assets$229$166$212$254
Other Assets$0$0$0$0
Total Assets$21,591$25,522$30,412$36,257
Liabilities
Payables$525$206$265$136
Short-Term Debt$29$52$92$78
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,946$1,770$1,680$1,056
Total Curr. Liab.$2,500$2,028$2,037$1,271
LT Debt$203$123$175$220
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$203$123$175$220
Other Liabilities$0$0$0$0
Cap. Leases$232$175$221$259
Total Liabilities$2,703$2,151$2,212$1,491
Equity
Pref Stock$0$0$0$0
Common Stock$322$311$309$301
Retained Earnings-$240,750-$228,196-$218,385-$204,790
AOCI$0$0$0$0
Other Equity$260,426$252,222$247,123$239,927
Total Equity$19,998$24,337$29,047$35,437
Supplemental Information
Minority Interest-$1,110-$966-$847-$671
Total Liab. & Tot. Equity$21,591$25,522$30,412$36,257
Net Debt-$1,039-$740-$12,093-$28,830
Anixa Biosciences, Inc. (ANIX) Financial Statements & Key Stats | AlphaPilot